Condition: Mitral Regurgitation · Sponsor: HighLife SAS
Feasibility, safety and performance of the HighLife CLARITY TSMV and its delivery system
This description comes directly from the study's public registry record.
Luc Verhees · +31 6 4270 2457 · lverhees@highlifemed.com
Always discuss trial participation with your own doctor first.
| Wesley Hospital | Auchenflower, Australia | Recruiting |
| Mount Hospital | Perth, Australia | Recruiting |
| Macquarie University Hospital | Sydney, Australia | Terminated |
| AZ St. Jan - Brugge | Bruges, Belgium | Recruiting |
| UZ Leuven | Leuven, Belgium | Recruiting |
| CHU Lille | Lille, France | Recruiting |
| Centre Hospitalo - Univ de Nantes | Nantes, France | Recruiting |
| CHU de Rennes | Rennes, France | Recruiting |
| Cliniue Pasteur | Toulouse, France | Recruiting |
| Deutsches Herzzentrum Munchen | Munich, Germany | Recruiting |
| University Hospital Ulm | Ulm, Germany | Recruiting |
| Medical University of Silesia | Katowice, Poland | Recruiting |
+ 2 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04888247